Literature DB >> 22960435

Motor symptoms at onset of Parkinson disease and risk for cognitive impairment and depression.

Richard B Dewey1, Aanchal Taneja, Shawn M McClintock, C Munro Cullum, Richard B Dewey1, Ira Bernstein, Mustafa M Husain.   

Abstract

OBJECTIVE: To determine whether side and type of initial motor symptoms in Parkinson disease (PD) predict risk for later development of cognitive impairment or depressive symptoms.
METHODS: We recruited 124 non-demented patients with PD to participate in a cohort study of cognitive function and depressive symptoms that used validated neuropsychological tests and a depressive symptom inventory. We first reviewed the patients' charts to determine their initial motor symptom and side of onset, and then classified the patients into 4 groups: right-sided onset tremor, right-sided onset bradykinesia/rigidity, left-sided onset tremor, and left-sided onset bradykinesia/rigidity. We excluded patients with bilateral symptom onset. We used analysis of variance on neuropsychological test performance and depressive symptoms to determine whether group classification affected risk of cognitive impairment or depressive symptoms. We controlled our analyses for disease duration and motor severity as measured by the Unified Parkinson Disease Rating Scale Part III motor score.
RESULTS: There were no differences in any cognitive measure by side and type of initial motor symptoms. The right-sided onset tremor group had the lowest depressive symptom scores, and no patient in any group reported severe depressive symptoms.
CONCLUSIONS: Our findings suggest that patterns of nigral cell loss correlating to the initial side and type of motor symptoms in PD are not related to the risk of later cognitive impairment. By contrast, patients with right-sided onset of tremor seem to have a lower risk of depressive symptoms than patients with other presentations.

Entities:  

Mesh:

Year:  2012        PMID: 22960435      PMCID: PMC3477612          DOI: 10.1097/WNN.0b013e31826dfd62

Source DB:  PubMed          Journal:  Cogn Behav Neurol        ISSN: 1543-3633            Impact factor:   1.600


  24 in total

Review 1.  Cognitive differences between patients with left-sided and right-sided Parkinson's disease. A review.

Authors:  Nele Verreyt; Gudrun M S Nys; Patrick Santens; Guy Vingerhoets
Journal:  Neuropsychol Rev       Date:  2011-09-29       Impact factor: 7.444

Review 2.  Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease.

Authors:  J R Slaughter; K A Slaughter; D Nichols; S E Holmes; M P Martens
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

3.  Left-sided Parkinson's disease is associated with greater anxiety and depression.

Authors:  S Fleminger
Journal:  Psychol Med       Date:  1991-08       Impact factor: 7.723

4.  Side of onset of motor symptoms influences cognition in Parkinson's disease.

Authors:  R Tomer; B E Levin; W J Weiner
Journal:  Ann Neurol       Date:  1993-10       Impact factor: 10.422

5.  Association between presenting motor symptoms and the risk of cognitive impairment in Parkinson's disease.

Authors:  M Viitanen; J A Mortimer; D D Webster
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-10       Impact factor: 10.154

Review 6.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

7.  Neuropsychological characteristics of parkinsonian patients with lateralized motor impairment.

Authors:  G Finali; M Piccirilli; S Rizzuto
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1995

8.  The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

Authors:  A John Rush; Madhukar H Trivedi; Hicham M Ibrahim; Thomas J Carmody; Bruce Arnow; Daniel N Klein; John C Markowitz; Philip T Ninan; Susan Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

9.  Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis.

Authors:  K Marder; D Leung; M Tang; K Bell; G Dooneief; L Cote; Y Stern; R Mayeux
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

10.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

Authors:  Dag Aarsland; Kjeld Andersen; Jan P Larsen; Anette Lolk; Per Kragh-Sørensen
Journal:  Arch Neurol       Date:  2003-03
View more
  10 in total

Review 1.  Neuroimaging with magnetoencephalography: A dynamic view of brain pathophysiology.

Authors:  Tony W Wilson; Elizabeth Heinrichs-Graham; Amy L Proskovec; Timothy J McDermott
Journal:  Transl Res       Date:  2016-01-25       Impact factor: 7.012

2.  Treatment of Dementia With Bosutinib: An Open-Label Study of a Tyrosine Kinase Inhibitor.

Authors:  Kennedy D Mahdavi; Sheldon E Jordan; Hannah R Barrows; Maša Pravdic; Barshen Habelhah; Natalie E Evans; Robin B Blades; Jessica J Iovine; Sergio A Becerra; Rachel A Steiner; Marisa Chang; Santosh Kesari; Alexander Bystritsky; Ed O'Connor; Hyman Gross; F Scott Pereles; Mike Whitney; Taylor Kuhn
Journal:  Neurol Clin Pract       Date:  2021-06

Review 3.  Neural and behavioral substrates of subtypes of Parkinson's disease.

Authors:  Ahmed A Moustafa; Michele Poletti
Journal:  Front Syst Neurosci       Date:  2013-12-24

4.  Side-of-onset of Parkinson's disease in relation to neuropsychological measures.

Authors:  Edward J Modestino; Chioma Amenechi; AnnaMarie Reinhofer; Patrick O'Toole
Journal:  Brain Behav       Date:  2016-10-19       Impact factor: 2.708

5.  Association of Parkinson Disease Induction with Cardiac Upregulation of Apoptotic Mediators P53 and Active Caspase-3: An Immunohistochemistry Study.

Authors:  Nour S Erekat; Muhammed D Al-Jarrah
Journal:  Med Sci Monit Basic Res       Date:  2018-08-23

6.  Gray and white matter alterations in different predominant side and type of motor symptom in Parkinson's disease.

Authors:  Jingwen Chen; Xianchen Jiang; Jingjing Wu; Haoting Wu; Cheng Zhou; Tao Guo; Xueqin Bai; Xiaocao Liu; Jiaqi Wen; Zhengye Cao; Luyan Gu; Wenyi Yang; Jiali Pu; Xiaojun Guan; Xiaojun Xu; Baorong Zhang; Minming Zhang
Journal:  CNS Neurosci Ther       Date:  2022-06-07       Impact factor: 7.035

7.  An Effective Method to Identify Shared Pathways and Common Factors among Neurodegenerative Diseases.

Authors:  Ping Li; Yaling Nie; Jingkai Yu
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

8.  REM Sleep Behavior and Motor Findings in Parkinson's Disease: A Cross-sectional Analysis.

Authors:  Abhimanyu Mahajan; Liana S Rosenthal; Charlene Gamaldo; Rachel E Salas; Gregory M Pontone; Arita McCoy; Chizoba Umeh; Zoltan Mari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-06-23

9.  Disease-Related Variables and Depression Among Iranian Patients with Parkinson Disease.

Authors:  Jalal Shakeri; Maryam Chaghazardi; Nasrin Abdoli; Farid Arman; Seyed Davood Hoseini; Hania Shakeri
Journal:  Iran Red Crescent Med J       Date:  2015-10-28       Impact factor: 0.611

10.  The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in Taiwan.

Authors:  Weng-Ming Liu; Ru-Jen Lin; Rwei-Ling Yu; Chun-Hwei Tai; Chin-Hsien Lin; Ruey-Meei Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2015-11-11       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.